Experiments were designed to look at the relationship between infective dos
e and disease severity using 2 clones of Plasmodium chabaudi that differ in
virulence. We asked whether there were dose-severity relationships, whethe
r clone differences in virulence were maintained over a range of doses, and
whether disease severity could be accounted for by parasite dynamics. Grou
ps of mice were infected with parasite doses differing by an order of magni
tude, ranging from 100 to I X 10(8), parasites. Infective dose affected the
probability of death, but only with the more virulent clone. Dose also aff
ected morbidity. For both clones, higher doses induced greater anaemia. Lar
ger doses caused greater weight loss, but only for infections with the more
virulent clone. Here, for a given dose, mice lost a fixed amount of weight
, irrespective of their initial weight. Larger doses induced earlier mortal
ity and morbidity than did lower dose treatments. Finally, dose affected pa
rasite dynamics, with earlier and higher peak parasite densities in larger
dose infections. All these effects were small relative to clone differences
in disease severity, which were apparent across the range of doses. Dose e
ffects were manifested through the timing and/or magnitude of peak parasite
densities, broadly supporting the idea that dose affects disease severity
by altering the time the host has to control parasite densities and amelior
ate the effects of parasites. We discuss the possible efficacy of intervent
ion strategies aimed at reducing human disease severity by reducing infecti
ve parasite dose.